Takeda and the Indonesian Government have announced a multi-phased collaboration to strengthen the country’s plasma ecosystem and expand access to PDMPs.
The funds will support the progression of MindRank’s pipeline, which is heavily dominated by obesity indications.
Teva Pharmaceuticals International and Polpharma Biologics have signed a global licensing agreement for a proposed biosimilar to Ocrevus to treat multiple sclerosis.
Apertura has entered a CRADA with various NIH institutes for a gene therapy to treat Niemann-Pick Disease Type C1 (NPC1).
Bayer's agreement with Apollo comes a little after Bayer broke its pharma dealmaking fast by acquiring Perfuse Therapeutics in May 2026.
Over 156,000 adults in Europe are hospitalised each year due to RSV, a virus that can cause severe lung issues.
AstraZeneca and Sino Biopharmaceutical's subsidiary CTTQ have signed an exclusive licence agreement for TQC3721.
Evogene and Tel Aviv University’s BCDD have partnered to expedite small-molecule drug discovery originating from Israeli academic research.
The FDA is taking action to curb the illicit online trade of unregulated and unapproved ketamine products through a slew of warning letters.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results